Evaluating an intervention to improve the safety and experience of transitions from hospital to home for older people (Your Care Needs You): a protocol for a cluster randomised controlled trial and process evaluation

TY - JOUR

T1 - Evaluating an intervention to improve the safety and experience of transitions from hospital to home for older people (Your Care Needs You)

T2 - a protocol for a cluster randomised controlled trial and process evaluation

AU - Lawton, Rebecca

AU - Murray, Jenni

AU - Baxter, Ruth

AU - Richardson, Gerry

AU - Cockayne, Sarah

AU - Baird, Kalpita

AU - Mandefield, Laura

AU - Brealey, Stephen Derek

AU - O'Hara, Jane

AU - Foy, Robbie

AU - Sheard, Laura

AU - Cracknell, Alison

AU - Breckin, Edmund

AU - Hewitt, Catherine

N1 - © The Author(s) 2023.

PY - 2023/12/14

Y1 - 2023/12/14

N2 - Background Older patients often experience safety issues when transitioning from hospital to home. The ‘Your Care Needs You’ (YCNY) intervention aims to support older people to‘know more’ and‘do more’ whilst in hospital so that they are better prepared for managing at home.Methods A multi-centre cluster randomised controlled trial (cRCT) will evaluate the efectiveness and cost-efectiveness of the YCNY intervention.Forty acute hospital wards (clusters) in England from varying medical specialities will be randomised to deliver YCNY or care-as-usual on a 1:1 basis. The primary outcome will be unplanned hospital readmission rates within 30 days of discharge. This will be extracted from routinely collected data of at least 5440 patients (aged 75 years and older) discharged to their own homes during the 4- to 5-month YCNY intervention period. A nested cohort of up to 1000 patients will be recruited to the study to collect secondary outcomes via follow-up questionnaires at 5-, 30-and 90-day post-discharge. These will include measures of patient experience of transitions, patient-reported safety events, quality of life and healthcare resource use. Unplanned hospital readmission rates at 60 and 90 days of discharge will be collected from routine data.A process evaluation (primarily interviews and observations with patients, carers and staff) will be conducted to understand the implementation of the intervention and the contextual factors that shape this, as well as the inter-vention’s underlying mechanisms of action. Fidelity of intervention delivery will also be assessed across all intervention wards.

AB - Background Older patients often experience safety issues when transitioning from hospital to home. The ‘Your Care Needs You’ (YCNY) intervention aims to support older people to‘know more’ and‘do more’ whilst in hospital so that they are better prepared for managing at home.Methods A multi-centre cluster randomised controlled trial (cRCT) will evaluate the efectiveness and cost-efectiveness of the YCNY intervention.Forty acute hospital wards (clusters) in England from varying medical specialities will be randomised to deliver YCNY or care-as-usual on a 1:1 basis. The primary outcome will be unplanned hospital readmission rates within 30 days of discharge. This will be extracted from routinely collected data of at least 5440 patients (aged 75 years and older) discharged to their own homes during the 4- to 5-month YCNY intervention period. A nested cohort of up to 1000 patients will be recruited to the study to collect secondary outcomes via follow-up questionnaires at 5-, 30-and 90-day post-discharge. These will include measures of patient experience of transitions, patient-reported safety events, quality of life and healthcare resource use. Unplanned hospital readmission rates at 60 and 90 days of discharge will be collected from routine data.A process evaluation (primarily interviews and observations with patients, carers and staff) will be conducted to understand the implementation of the intervention and the contextual factors that shape this, as well as the inter-vention’s underlying mechanisms of action. Fidelity of intervention delivery will also be assessed across all intervention wards.

U2 - 10.1186/s13063-023-07716-z

DO - 10.1186/s13063-023-07716-z

M3 - Article

SN - 1745-6215

VL - 24

JO - Trials

JF - Trials

M1 - 671

ER -